ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625498 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625498; 2) Community: the network communities that were significantly associated with the response to NSC 625498; 3) Molecule: the relationships between components within communities and NSC 625498; 4) MDR: the compounds that were significantly associated with the NSC 625498.

NSC Compound Enrichment Correlation
NSC 658837 Null 0.00563900078161125 0.36020512
NSC 726217 Combretastatin A4-analogue 0.00563900078161125 0.29646243
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.00563900078161125 0.50287072
NSC 756483 SB-742864 0.00563900078161125 0.42404747
NSC 762346 Null 0.00563900078161125 0.21756145
NSC 251667 ERIOFLORIN ACETATE 0.00592008956008464 0.4822948
NSC 302035 Melampodin B acetate 0.00592008956008464 0.46903465
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.00592008956008464 0.44640027
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.00592008956008466 0.52715585
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.00648124190744032 0.42916928
Total:86  Current:11    [First] [Prev] [Next] [Last]